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Abstract: Pattern recognition receptors (PRRs) constitute a pivotal arm of innate immunity. Their distribution
is widespread and not limited to cells of the immune system. Following our previous findings concerning the
expression of Toll-like receptors (TLRs) 2, 3 and 4 in chronic viral hepatitis C of children, we wished to search for
other PRRs, including other TLRs, NOD-like receptors (NLRs) and RIG-1-like helicase receptors (RLR) in
infected hepatocytes. Liver biopsy fragments from ten children with chronic hepatitis B and C were used and two
others in which hepatotropic virus infection was excluded. Frozen sections of liver samples were subjected to ABC
immunohistochemistry (IHC) following incubation with a set of antibodies. Results of IHC findings were screened
for correlation with clinical/laboratory data of patients. It was found that several PRRs could be shown in affected
hepatocytes, but the incidence was higher in hepatitis C than in B. In hepatitis C, TLR1, 2, 4, NALP and RIG-1
helicase showed the most marked expression. In hepatitis B, TLR1, 3, 9, NOD1 and NALP expression were the
most conspicuous. Expression PRRs in liver from hepatitis of unknown origin was much lower. It was also the case
in cytospins from human hepatoma cell line. Several correlations between PRRs expression and clinical findings in
patients could be shown by statistical exploration. In conclusion, this data suggests some role for PRRs in the
pathogenesis of chronic viral hepatitis. (Folia Histochemica et Cytobiologica 2011; Vol. 49, No. 3, pp. 410–416)
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Introduction
Hepatotropic viruses, both hepatitis B virus (HBV)
and hepatitis C virus (HCV), remain important patho-
genic agents of man, including children. Both viruses
rarely induce acute hepatitis in young patients. Symp-
tomless periods of infection quite often lead, howev-
er, to the chronic stage of the disease with several
consequences such as liver cirrhosis and hepatocel-
lular carcinoma [1]. The pathogenesis of chronic vi-
ral hepatitis is relatively well known. Viruses induce
an adaptive immune response in the infected host,
which however is usually unable to eradicate them
from the body. Activation of the immune effector
mechanisms results in liver tissue damage with sub-
sequent proliferation of connective tissue ensuing in
411Pattern recognition receptors in chronic viral hepatitis
©Polish Society for Histochemistry and Cytochemistry
Folia Histochem Cytobiol. 2011
10.5603/FHC.2011.0058
www.fhc.viamedica.pl
cirrhosis. Both viruses are apparently not cytopathic
[2, 3]. The inefficiency of adaptive immune response
in dealing with viral infection shifted interest toward
innate immune mechanisms. The latter dominate in
invertebrate animals, being successful against various
infections. They were shown to be active in human
beings and to influence the course of human diseas-
es, including viral hepatitis [4–6].
Pattern recognition receptors (PRRs) are consid-
ered now to play a pivotal role in innate immunity.
They are expressed predominantly on cells of the
immune system, but have been also shown on various
epithelia, including hepatocytes [7, 8]. PRRs are ex-
pressed on immune cells, especially on antigen-pre-
senting ones (APC), and participate in the induction
of adaptive immunity. Ligands recognized by PRRs
are the molecules present on or in pathogens such as
viruses, bacteria, fungi and protozoa, being essential
for their growth and survival. They include various
complex lipids, sugars, nucleic acids, collectively
termed pathogen-associated molecular patterns
(PAMPs). PRRs comprise several families including
Toll-like receptors (TLRs), NOD — nucleotide bind-
ing oligomerization domain like receptors (NLRs) and
Rig-like helicase receptors (RLR). The best known
are TLRs, subdivided now into 11 subgroups in man,
according to the specificity of recognized PAMPs.
NLRs are relatively newly described intracellular
PRRs, consisting of at least 22 members, activated
mainly by various bacterial peptidoglycans. RLRs are
also intracellular and participate in antiviral defense
by promoting type I interferon (IFN) synthesis [9–11].
We have shown three TLRs, namely TLR2, 3 and
4 in liver biopsy tissue sections of children chronical-
ly infected with HCV [8]. In the current study, we
wanted to learn whether other TLRs, some NLRs and
RLRs are also expressed in infected hepatocytes of
children suffering from both chronic HBV and HCV
hepatitis. Furthermore, we wished to seek a possible
relationship between PRRs expression and clinical data
of infected children. It will be shown, albeit on a small
group of patients, that some links between PRR ex-
pression and clinical status of patients really do exist.
Material and methods
Patients. They were five children, all boys, chronically in-
fected with HBV, aged from six to 14 years, (median age
9.6 years.). Their diagnosis was confirmed both by sero-
logical and molecular criteria. Another five children had
chronic hepatitis C, including four boys and one girl, aged
from eight to 17 years (median age 14.4 years). HCV in-
fection was based on the criteria as above. All ten patients
were subjected to percutaneous liver biopsy in order to
establish advancement of disease. Informed consent for
this procedure was obtained either from parents or the
children themselves. Clinical and laboratory data of the
patients is shown in Table 1.
Apart from the infected patients, two other boys of com-
parable age were tested along with those shown above, in
which HBV and HCV infection was excluded, but liver bi-
opsy was performed for diagnostic purposes. In the first boy,
chronic hepatitis of unknown origin was diagnosed. In the
second, a diagnosis of autoimmune hepatitis was finally es-
tablished. In addition, cell sediments from human hepato-
ma cell line were tested in parallel. These three specimens
were later called ‘others’.
ABC immunohistochemistry. In brief, fragments of liver
tissue obtained during biopsy were snap-frozen in dry ice-
acetone slurry and stored at –70°C until used. Cryostat
4 μm sections from liver blocks were then cut (n = 4–5), po-
sitioned on each microscopic slide, air-dried, fixed for 5 min
in the cold acetone. Endogenous peroxidase was abolished
by the treatment of sections with methanol with 0.6% hy-
drogen peroxide for 20 minutes. To avoid non-specific stain-
ing, sections were incubated with 1.5% normal goat serum
for one hour.
Primary goat anti-particular PRR antibody was then ap-
plied and sections were incubated overnight in a humid
chamber in the cold. Primary goat anti-PRRs antibodies
used were all from Santa Cruz Biotechnology, CA, USA,
and were the same as used previously [12]. The next day,
sections were washed thrice with cold PBS and thereafter
subjected to biotinylated donkey anti-goat IgG for 30 min.
After washing, the next incubation was with avidin solution,
followed by biotinylated horseradish peroxidase (HRP).
After subsequent washing steps, substrate solution contain-
ing hydrogen peroxide and diaminobenzidine (DAB) was
applied. After washing, sections were counterstained with
Meyer hematoxylin and embedded in glycerogel. For the
whole ABC procedure, a commercial kit (Santa Cruz) was
used. Negative control reactions included:
— omitting primary antibody and using normal goat se-
rum instead;
— performing the reaction on sections of normal human
liver (from surgery).
Both control reactions came out completely negative.
As a positive control reaction, frozen sections of hu-
man tonsil were run in parallel. This was of limited value,
because several PRRs could not be demonstrated in lym-
phoid cells.
Additionally, cell cytospins of human hepatoma (Hep-62)
cell line were subjected to the same immunohistochemical
procedure as above. Primary antibodies applied were the
same as those used for tissue sections.
Evaluation of immunohistochemical reactions. At least
ten microscopic fields at magnification × 400 were analyzed
visually and scored under microscope by two independent
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observers. Intensity of positive staining and the number of
positive cells were estimated semiquantitatively in numeri-
cal scores from 0 to 3: 0 — lack of positive cells; 1 — up to
10 % of positive cells; 2 — 11–50 % of positive cells; 3 —
51–100 % of positive cells.
Statistical analysis. Differences between sums of numeri-
cal PRRs scores in individual patients of HBV, HCV and
the ‘other group’ was tested by ANOVA and post-hoc test
of minimal significant difference between results. In order
to search for correlation between clinical/laboratory data
of patients, results were converted into sets of parameters
of descriptive statistics (mean, standard error, standard de-
viation, number of results). Statistical analysis was performed
by means of precise non-parametric tools such as Mann–
–Whitney test, and Spearman’s correlation coefficient. For
final statistics, a StatXact (Cytel Co.) program was applied.
Results
All infected children, both HCV+ and HBV+, mani-
fested viremia in the blood. Values of hepatic enzymes
(ALT and AST) were raised in almost all patients,
but the rise was higher in the HBV+ group. Histology
of biopsy specimens showed weakly expressed changes
in the majority of patients classified as G1S1. All chil-
dren, with the exception of one (K.P.), were before
antiviral therapy. Clinical and laboratory data of all
patients tested is set out in Table 1.
When frozen sections of biopsy liver tissue frag-
ments were subjected to PRR antibodies and ABC
immunohistochemistry (IHC), the results varied from
patient to patient and from one PRR to another
(Table 2). In general, the number of PRR positive liv-
er samples and number of scores in individual cases
were higher in hepatitis C than in hepatitis B biopsies.
Within the TLRs family, approximately the same recep-
tors were most frequently expressed in both diseases
tested. They included TLR1, 2, 3, 4, 9 and 10. In the
NLR group, all receptors tested, namely NOD1,
NOD2, NALP1, Cryopiryn (NALP3) and CARD12,
were more strongly expressed in hepatitis C compared
to hepatitis B liver sections. In the RNL group repre-
sented by two receptors, RIG-1 and MDA-5, the
former predominated, mainly in hepatitis C samples.
Examples of IHC staining are shown in composite
Figure 1 (A–H). As can be seen in Table 2, mean val-
ues of numerical scores were higher in hepatitis C
than in hepatitis B for almost all PRRs tested. The
mean of the so called ‘control group’ was lower than
those of both examined groups. The only exception
was the mean of cryopiryn (NALP3) in which the
mean in hepatitis B was lower than in the ‘control’
group.
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Figure 1. A. Frozen section of liver from HBV+ patient. Abundant inflammatory infiltrate is seen. No positive staining in
surrounding hepatocytes. ABC reaction but instead of primary antibody- PBS (control); B. As above, but primary Ab anti
TLR7. Cytoplasmic reaction in most hepatocytes; C. Frozen section of liver from HCV+ patient. Ab anti TLR9. Most
liver cells show intensive cytoplasmic staining; D. As above, but Ab anti TLR10. Only some hepatocytes are positive;
E. As above, but Ab anti NOD1. Diffuse cytoplasmic reaction in most hepatocytes; F. As above, but Ab anti NALP1.
Irregular cytoplasmic staining of hepatocytes; G. As above, but Ab anti CARD12. Majority of cells are positive;
H. As above, but higher magnification. Irregular distribution of positive and negative cells; Bar — 50 μm
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The numerical scores of all PRRs for individual
patients were also added and divided by the number
of PRRs tested. The sum of these values in hepatitis
B (n = 5) was compared to that in hepatitis C. It
turned out that the sum of hepatitis B was lower than
that of hepatitis C (6.2 vs. 8.0). When these values
were subjected to ANOVA and post-hoc statistics, the
difference between HBV and HCV sums was not sig-
nificant, but between HCV and the ‘others’ it was
(p = 0.020). There was no visible correlation between
total PRR counts and clinical/laboratory data in
HBV+ patients. In the HCV+ group, however, the
highest combined PRR value was noticed in the pa-
tient (BA) with the highest viremia.
The so-called ‘others’ group included one hepati-
tis of unknown origin, HBV and HCV negative. Its
liver specimens were largely negative or weakly posi-
tive with all anti-PRR antibodies. The second liver
sample, later diagnosed as autoimmune hepatitis,
came out positive or weakly positive with most of the
antibodies tested. The third ‘others’ sample, hepato-
ma cell line (Hep-62) cytospins, were negative with
the exception of Cryopiryn and Rig-1 antibodies.
Evaluation of clinical/laboratory data and
PRR values by statistical analysis
An attempt was made to search for the relationships
between clinical/laboratory data and results of PRR
by IHC. The following correlations were observed:
1. Significant difference of NOD2 expression betwe-
en hepatitis B and C (p = 0.03);
2. Borderline significant difference of NOD1 expres-
sion between hepatitis B and C (p = 0.08);
3. Borderline significant difference of TLR4 expres-
sion between hepatitis B and C (p = 0.08);
Correlation between various parameters tested
and viremia was assessed jointly for hepatitis B
and hepatitis C group;
4. Significant correlation was shown between vire-
mia and ALT activity (r = 0.68, p = 0.02);
5. Significant correlation was shown between vire-
mia and AST activity (r = 0.82, p = 0.005);
6. Significant correlation was demonstrated between
viremia and TLR3 expression (r = –0.64, p = 0.04);
7. Borderline significance was noted between vire-
mia and CARD12 expression (r = 0.53, p = 0.07);
8. Borderline significance was also noted between
viremia and cryopiryn (r = 0.55, p = 0.06).
Discussion
The results presented here show that human hepato-
cytes infected either with HBV or HCV express sev-
eral PRRs. In hepatitis B, the most frequent incidence
of TLRs included TLR1, 2, 3, 4, 9 and 10, but also
NOD1 and NALP1. In hepatitis C, the same PRRs
appeared the most frequently, but also NOD2, Cry-
opiryn (NALP3) and RIG1- like helicase could be
demonstrated. It is of interest that hepatocytes from
an autoimmune hepatitis case have shown a similar
pattern of PRR expression to those of a chronic viral
one. This suggests that PRRs ligands may be analo-
gous in both pathological conditions. The reason for
such vast PRR expression in these diseases is unknown
and any attempts of explanation can only be specula-
tive. Wei et al. [7] have found however, that TLR4
expression in hepatocytes positively correlated with
grading scores. In the current study, it was not possi-
ble to pinpoint any rules governing PRR expression
in individual liver specimens. PRRs do not recognize
only PAMPs i.e. molecular patterns of various patho-
gens. Some of them recognize however products of
metabolism or degradation of the body such as uric
acid, apoptotic bodies, heat shock proteins and oth-
ers, collectively termed ‘Danger Associated Molecu-
lar Patterns’ (DAMPs). It is likely that several meta-
bolic end-products formed intracellularly in infected
hepatocytes may be recognized by intracellular PRRs
such as NLRs. It is known that some NLRs such as
NALP3 form intracellular multimolecular complex
with caspase-1 termed inflammasome involved in the
regulation of secretion of proinflammatory cytokines
such as IL-1 [10]. It certainly might trigger an inflam-
matory reaction against DAMPs. The latter are ap-
parently abundant in liver cells due to the high meta-
bolic turnover in this organ. Activators of NLRs are
poorly understood. It is known, for example, that
NALPs, members of the NLR family, may be trig-
gered by hypotonic stress, possibly due to the release
or activation of some ‘danger signal’ [13–16]. Such
danger signals may originate from cell degradation
product following viral infection. NLRs were so far
known to be triggered by bacterial peptidoglycans,
components of bacterial cell wall. The data from the
current study indicates that they can be also triggered
by other molecules, not necessarily of bacterial origin.
Higher expression of PRRs in hepatitis C samples
compared to HBV ones, although not significant, sug-
gests some hints for this conundrum. As shown in
Table 2, means of almost all PRRs were higher in the
former group. The sums of numerical values of indi-
vidual patients divided by the number of PRRs test-
ed were also higher in the HCV group. One possible
explanation of the difference in the PRR expression
in infected hepatocytes by HCV as compared to HBV
ones may be the median age of affected children. The
HBV group was younger than the HCV one. This may
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imply some immaturity of the immune system and
some metabolic processes within cells governing
PRRs responses both to viral and own wasted prod-
ucts corresponding to PAMPs and DAMPs. Recently
new roles for PRR NLRs in the liver have been pro-
posed. It has been shown that hepatocytes express
functional NOD1 and NOD2. Stimulation of NOD1
with its ligand (C12-iEDAP) resulted in NF-kappa B
activation, CCL5 (RANTES) and CXCL1 chemokine
production [17]. In hepatitis C, it was postulated that
HCV can subvert PRRs mediated control of adap-
tive immunity dependent on dendritic cells [18]. Com-
ponents of RLR family were less frequently demon-
strated in examined biopsies. Nevertheless, RIG-1 like
helicase was seen in two cases of hepatitis B and in
three ones of hepatitis C, while MDA-5 was evident
in only one hepatitis B specimen. This may correspond
to the relatively low inflammatory intensity in most
examined liver tissues as depicted by grading and stag-
ing (G1S1) scores. On the other hand, it is known that
RLRs and in particular RIG-1 helicase participate in
triggering type I interferon secretion following viral
infection [19]. It has been shown recently by Hoffman
et al. that RIG-1 polymorphism has an influence on its
activity during HCV infection [20].
In spite of the small number of patients, we decid-
ed to search for possible correlations between PRR
expression and some clinical/laboratory data, being
aware of its constraints. Unexpectedly, some correla-
tions could be noticed, either significant or border-
line. The former included higher expression of NOD2
in hepatitis C compared to B and relatively frequent
incidence of TLR3 in both hepatidines. The latter
finding may be the reflection of viral etiology of both
diseases and TLR3 propensity for nucleic acids. It was
further supported by the presence of significant cor-
relation between TLR3 and viremia. TLR3 has also
shown borderline correlation with two NLR members,
namely CARD12 (caspase recruitment domain) and
cryopiryn (NALP3). The reasons for this are obscure,
but it is well known that caspase activation is associ-
ated with apoptosis (hepatocytes?).
In conclusion, it appears tempting to postulate that
PRRs play some role in the pathogenesis of viral hep-
atitis B and C. This is supported even by their vast
expression in the hepatocytes of an affected liver, and
virtually total absence, at least by IHC screening, from
normal ones.
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